Today's Research Reports on Trending Tickers: Tandem Diabetes Care and MiMedx
NEW YORK, NY / ACCESSWIRE / November 8, 2018 / U.S. markets advanced on Wednesday as the midterm election results went according to market expectations. The Democrats took over the House, while the Republicans remained in control of the Senate. The Dow Jones Industrial Average jumped 2.13 percent to close at 26,180.30, while the S&P 500 Index hiked 2.12 percent to close at 2,813.89. The Nasdaq Composite Index closed 2.64 percent higher to close at 7,570.75.
“As President Trump plans his 2020 reelection campaign, a gridlocked Congress is unlikely to deliver any notable wins to help expand his agenda. Therefore, Trump will likely focus on his broad executive powers to affect trade and national security,” said Sun Life Investment Management managing director, investment strategy, Dec Mullarkey.
RDI Initiates Coverage on:
Tandem Diabetes Care, Inc.
https://rdinvesting.com/news/?ticker=TNDM
MiMedx Group, Inc.
https://rdinvesting.com/news/?ticker=MDXG
Tandem Diabetes Care' stock jumped 7.5% Wednesday, to close the day at $39.56. The stock recorded a trading volume of 1,936,031 shares, which was below its three months average volume of 3,261,383 shares. In the last year, Tandem Diabetes Care' shares have traded in a range of 2.14 - 52.55. The share price has gained 1748.6% from its 52 week low. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $38.18 is above its 200-day moving average of $27.84. Shares of Tandem Diabetes Care have gained roughly 7.35 percent in the past month and are up 1576.27 percent year-to-date.
Access RDI's Tandem Diabetes Care, Inc. Research Report at:
https://rdinvesting.com/news/?ticker=TNDM
On Wednesday, shares of MiMedx recorded a trading volume of 28,305,130 shares, which was above the three months average volume of 2,320,016 shares. The stock ended the day 41.16% lower at $3.66. The share price has fallen 79.95% from its 52 week high with a 52 week trading range of 3.01 - 18.25. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $5.69 is above its 200-day moving average of $5.66. Shares of the company are trading at a Price to Earnings ratio of 11.77. Shares of MiMedx have fallen roughly 35.22 percent in the past month and are down 70.98 percent year-to-date.
Access RDI's MiMedx Group, Inc. Research Report at:
https://rdinvesting.com/news/?ticker=MDXG
Our Actionable Research on Tandem Diabetes Care, Inc. (NASDAQ:TNDM) and MiMedx Group, Inc. (NASDAQ:MDXG) can be downloaded free of charge at Research Driven Investing.
Research Driven Investing
We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.
RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.
Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker-dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.
CONTACT
For any questions, inquiries, or comments reach out to us directly at:
Address:
Email:
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE: RDInvesting.com
